TY  - GEN
AU  - Pappo,A S
AU  - Bowman,L C
AU  - Furman,W L
AU  - Rao,B N
AU  - Kun,L E
AU  - Jenkins,J J
AU  - Crom,W R
AU  - Luo,X
AU  - Kaste,S C
AU  - Avery,L
AU  - Meyer,W H
AU  - Shapiro,D N
AU  - Crist,W M
TI  - A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcoma
SN  - 1077-4114
PY  - 1997///1031
KW  - Adolescent
KW  - Antimetabolites, Antineoplastic
KW  - adverse effects
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Child
KW  - Child, Preschool
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Male
KW  - Methotrexate
KW  - Neoplasm Staging
KW  - Radiography
KW  - Rhabdomyosarcoma
KW  - diagnostic imaging
KW  - Risk Assessment
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1097/00043426-199709000-00006
ER  -